CIPRALEX -20MG
CIPRALEX -20MG
Approved
DIN Number
02263254
Drug Class
Human
Market Date
Feb 14, 2005
Company
HC
Lundbeck Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02263254
AIG Number0150435004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06AB10 ESCITALOPRAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.04.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
ESCITALOPRAM (ESCITALOPRAM OXALATE)Active
Strength: 20 MG
Monograph: ESCITALOPRAM (ESCITALOPRAM OXALATE)